$50,000 of TAKEDA PHARMACEUTICALS AMERICA INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"International tax reform."
You can find more data on corporate lobbying on Quiver Quantitative.
TAK Insider Trading Activity
TAK insiders have traded $TAK stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $TAK stock by insiders over the last 6 months:
- ANDREW STEWART PLUMP (President, R&D) has made 0 purchases and 3 sales selling 301,235 shares for an estimated $5,339,938.
- JULIE SO-YOUNG KIM (President and CEO) sold 89,090 shares for an estimated $1,523,439
- LAUREN RUSCKOWSKI DUPREY (Chief Transformation Officer) has made 0 purchases and 2 sales selling 82,121 shares for an estimated $1,453,999.
- NICOLA DEIDRE PETAL GREENWAY (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 54,357 shares for an estimated $956,731.
- TERESA MARIE BITETTI (President, OBU) sold 50,012 shares for an estimated $855,205
- GILES RICHARD PLATFORD (President, IBU) sold 31,083 shares for an estimated $531,519
- NATALIE ANNE MARIE FURNEY (Global General Counsel) sold 30,868 shares for an estimated $527,842
- GABRIELE RICCI (Chief Data & Tech. Officer) sold 25,088 shares for an estimated $429,004
- ELAINE MARY SHANNON (Pres., Global Supply & Quality) has made 0 purchases and 2 sales selling 24,341 shares for an estimated $425,394.
- AGOSTI MARCELLO PIGNAGNOLI (Head, Strat. & Port. Dev) sold 22,957 shares for an estimated $392,564
- RHONDA JANICE PACHECO (President, U.S. Business Unit) sold 16,901 shares for an estimated $289,007
- AWNY SAMAAN BOTROS FARAJALLAH (Chief Medical Officer) sold 14,006 shares for an estimated $239,502
- RAMY RIAD AHMED IBRAHIM (President, PDT BU) sold 7,277 shares for an estimated $124,436
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
TAK Hedge Fund Activity
We have seen 199 institutional investors add shares of TAK stock to their portfolio, and 132 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,481,816 shares (+34.9%) to their portfolio in Q2 2026, for an estimated $39,783,510
- D. E. SHAW & CO., INC. removed 2,244,283 shares (-52.3%) from their portfolio in Q2 2026, for an estimated $35,975,856
- QUBE RESEARCH & TECHNOLOGIES LTD added 2,207,432 shares (+inf%) to their portfolio in Q2 2026, for an estimated $35,385,134
- UBS GROUP AG removed 1,828,910 shares (-66.7%) from their portfolio in Q2 2026, for an estimated $29,317,427
- MILLENNIUM MANAGEMENT LLC added 1,050,698 shares (+inf%) to their portfolio in Q2 2026, for an estimated $16,842,688
- CAPITAL WEALTH PLANNING, LLC removed 886,835 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $14,215,965
- JPMORGAN CHASE & CO added 744,916 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,941,003
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
